Abstract:Objective To evaluate the efficacy and safety of endoscopic ligation for internal hemorrhoids combined with endoscopic injection sclerotherapy for hemorrhoidal bleeding in patients with liver cirrhosis.Methods We retrospectively enrolled 60 patients with hemorrhoidal bleeding and concomitant liver cirrhosis treated in our hospital between December 2020 and March 2025. Patients were allocated to an endoscopic ligation for internal hemorrhoids group (ligation group, n = 30) or an endoscopic ligation for internal hemorrhoids plus endoscopic injection sclerotherapy group (combined group, n = 30) according to the actual endoscopic regimen. Intraoperative blood loss, procedure time, wound healing time, length of hospital stay, visual analogue scale (VAS) scores for pain at multiple postoperative time points, clinical efficacy (cure rate and overall response), and postoperative complications were compared.Results Compared with the ligation group, the combined group had less intraoperative blood loss, shorter wound healing time and hospital stay, lower VAS scores at 12 h, 1 d, 3 d and 7 d after treatment, higher cure rate and overall response, and lower overall complication rate, the differences were statistically significant (P 0.05).Conclusion For liver cirrhosis patients with hemorrhoidal bleeding, endoscopic ligation for internal hemorrhoids combined with endoscopic injection sclerotherapy provides superior perioperative hemostasis, less pain, faster recovery, and fewer complications than endoscopic ligation for internal hemorrhoids alone. It is worth applying in clinical practice.